$2.61
0.00140.05%
Pre-Market: 8:41 AM EDT
Comments
Loading...
Vistagen Therapeutics (NASDAQ:VTGN) Stock, Earnings Estimates, EPS, And Revenue
Vistagen Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 11
EPS Estimate
$-0.460
Quarterly Revenue Estimate
$220K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$876K
Analyze the earnings history of Vistagen Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Vistagen Therapeutics (VTGN) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-07 | $-0.42 | $-0.39 | -7.69 % |
| Jun 2024 | 2024-08-13 | $-0.35 | $-0.40 | 12.5 % |
| Mar 2024 | 2024-06-11 | $-0.25 | $-0.37 | 32.4 % |
| Dec 2023 | 2024-02-13 | $-0.22 | $-0.30 | 26.7 % |
Vistagen Therapeutics (VTGN) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-07 | $183.00K | $220.00K | -16.8 % |
| Jun 2024 | 2024-08-13 | $84.00K | $300.00K | -72.0 % |
| Mar 2024 | 2024-06-11 | $197.30K | $410.00K | -51.9 % |
| Dec 2023 | 2024-02-13 | $411.40K | $540.00K | -23.8 % |
FAQ
When is Vistagen Therapeutics (NASDAQ:VTGN) reporting earnings?
Vistagen Therapeutics (VTGN) is scheduled to report earnings on February 11, 2025. The last reported earnings were for reported on November 7, 2024 for Q2.
What were the latest earnings per share (EPS) for Vistagen Therapeutics (NASDAQ:VTGN)?
The Actual EPS was $-0.42, which missed the estimate of $-0.39.
What were Vistagen Therapeutics’s (NASDAQ:VTGN) revenues?
The Actual Revenue was $183K, which missed the estimate of $220K.
Browse earnings estimates, EPS, and revenue on all stocks.